US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Test D

Reason Lack of assurance of sterility for injectables and solutions intended to be sterile.

Customceutical Compounding D-1259-2019
Class II · Moderate risk Terminated

Test D

Reason Lack of assurance of sterility for injectables and solutions intended to be sterile.

Customceutical Compounding D-1258-2019
Class II · Moderate risk Terminated

Lipoplex

Reason Lack of assurance of sterility for injectables and solutions intended to be sterile.

Customceutical Compounding D-1257-2019
Class II · Moderate risk Terminated

BPlex

Reason Lack of assurance of sterility for injectables and solutions intended to be sterile.

Customceutical Compounding D-1254-2019
Class II · Moderate risk Terminated

BPlex

Reason Lack of assurance of sterility for injectables and solutions intended to be sterile.

Customceutical Compounding D-1253-2019
Class II · Moderate risk Terminated

Prostaglandin Tri-Mix 30:30:1 Injection

Reason Lack of sterility assurance.

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1204-2019
Class II · Moderate risk Terminated

Prostaglandin Tri-Mix 20:25:1 Injection

Reason Lack of sterility assurance.

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1203-2019
Class II · Moderate risk Terminated

Prostaglandin Tri-Mix 5:15:0.5 Injection

Reason Lack of sterility assurance.

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1200-2019
Class II · Moderate risk Terminated

Phenol 10% Injection

Reason Lack of sterility assurance.

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1199-2019
Class II · Moderate risk Terminated

Papaverine 30 mg/mL Injection

Reason Lack of sterility assurance.

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1198-2019
Class II · Moderate risk Terminated

Papaverine 30 mg/Phentolamine 0.5 mg/mL

Reason Lack of sterility assurance.

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1197-2019
Class II · Moderate risk Terminated

Hcg 11

Reason Lack of sterility assurance.

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1196-2019
Class II · Moderate risk Terminated

Estrone 5mg/mL Oil Injection

Reason Lack of sterility assurance.

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1195-2019
Class II · Moderate risk Terminated

Heparin 20

Reason Lack of sterility assurance.

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1191-2019
Class II · Moderate risk Terminated

Sodium Bicarbonate 8.4% Injection

Reason Lack of sterility assurance.

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1190-2019
Class II · Moderate risk Terminated

EDTA 1% Sterile Injection

Reason Lack of sterility assurance.

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1189-2019
Class II · Moderate risk Terminated

Lidocaine 1%/Dextrose 12.5%

Reason Lack of sterility assurance.

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1188-2019
Class II · Moderate risk Terminated

Neomycin 40 mg/Polymixin B 200

Reason Lack of sterility assurance.

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1187-2019